World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
55665
World Ranking
14336
National Ranking
7247

James H. Chesebro publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where James H. Chesebro sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 290 publications — 15th percentile

15% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

James H. Chesebro D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where James H. Chesebro sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

James H. Chesebro is affiliated with the University of Massachusetts Chan Medical School in the United States. Their work is associated primarily with this institution, contributing to the academic and research environment there.

There are no recorded recent papers, co-authors, publication venues, book publications, fields of study, subfields, main topics, or awards available in the provided data to detail specific contributions or areas of research interest.

The absence of detailed publication and research information limits the ability to delineate specific academic focuses or thematic orientations in Chesebro's work. Nonetheless, their professional connection to a medical school suggests an involvement in health or medical research contexts, though this cannot be confirmed from the given data.

Due to the limited available data, no additional insights regarding the scientist's career trajectory, collaborative networks, or scholarly outputs can be provided at this time.

Best Publications

  • The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

    Valentin Fuster;Lina Badimon;Juan J. Badimon;James H. Chesebro

  • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

    Maarten Simoons;Eric Topol;Robert Califf;Frans van de Werf

  • From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

    Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells

  • Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

    J H Chesebro;G Knatterud;R Roberts;J Borer

  • Coronary artery disease: pathogenesis and acute coronary syndromes.

    Stephen G. Worthley;Julio I. Osende;Gérard Helft;Juan J. Badimon

  • Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

    J. H. Chesebro;G. Knatterud;R. Roberts;J. Borer

  • Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation.

    John H. Ip;Valentin Fuster;Lina Badimon;Juan Badimon

  • The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy

    Virginia V. Michels;Patricia P. Moll;Fletcher A. Miller;A. Jamil Tajik

  • Tissue Factor Modulates the Thrombogenicity of Human Atherosclerotic Plaques

    V Toschi;R Gallo;M Lettino;J T Fallon

  • Balloon angioplasty. Natural history of the pathophysiological response to injury in a pig model.

    P M Steele;J H Chesebro;A W Stanson;D R Holmes

  • Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.

    Richard Gallo;Adrian Padurean;Thottala Jayaraman;Steven Marx

  • Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial.

    Michael E. Farkouh;Howard Kirshner;Robert A. Harrington;Sean Ruland

  • Effects of Lipid-Lowering by Simvastatin on Human Atherosclerotic Lesions A Longitudinal Study by High-Resolution, Noninvasive Magnetic Resonance Imaging

    Roberto Corti;Zahi A. Fayad;Valentin Fuster;Stephen G. Worthley

  • Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial.

    Edwin G. Bovill;Michael L. Terrin;David C. Stump;Andrew D. Berke

  • Insights into the pathogenesis of acute ischemic syndromes

    V Fuster;L Badimon;M Cohen;J A Ambrose

  • A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass Operations: Benefit of Perioperative Dipyridamole and Aspirin Therapy on Early Postoperative Vein-Graft Patency

    J. H. Chesebro;I. P. Clements;V. Fuster;L. R. Elveback

  • Effect of Dipyridamole and Aspirin on Late Vein-Graft Patency after Coronary Bypass Operations

    James H. Chesebro;Valentin Fuster;Lila R. Elveback;Ian P. Clements

  • Atherosclerotic plaque rupture and thrombosis. Evolving concepts.

    V Fuster;B Stein;J A Ambrose;L Badimon

  • Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.

    M Cohen;P C Adams;G Parry;J Xiong

  • Mechanisms Determining Course and Outcome of Diabetic Patients Who Have Had Acute Myocardial Infarction

    Doron Aronson;Elliot J. Rayfield;James H. Chesebro

Frequent Co-Authors

Valentin Fuster
Valentin Fuster Icahn School of Medicine at Mount Sinai
Juan J. Badimon
Juan J. Badimon Icahn School of Medicine at Mount Sinai
Lina Badimon
Lina Badimon Hospital de la Santa Creu i Sant Pau
John T. Fallon
John T. Fallon East Carolina University
David R. Holmes
David R. Holmes Mayo Clinic
Richard L. Gallo
Richard L. Gallo University of California, San Diego
Robert L. Frye
Robert L. Frye Mayo Clinic
Bernard J. Gersh
Bernard J. Gersh Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative career options in healthcare and allied fields can open up numerous opportunities beyond traditional medical programs. For those interested in health promotion and wellness, an online nutrition degree can lead to roles in community health, food services, or research.

If you're passionate about healthcare leadership or administration, consider accredited mha programs that are designed to prepare students for management positions in hospitals and public health organizations. Similarly, registered nurses can advance their qualifications by enrolling in an rn to bsn with no clinicals program, which allows for further education without on-site clinical requirements.

For those already holding advanced nursing degrees, dnp online programs are available to help you reach the highest level of clinical nursing practice. Each of these flexible online pathways offers unique benefits, making it easier to balance studies with work or family commitments.

Best Scientists Citing James H. Chesebro

Trending Scientists

Recently Published Articles